These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 7585861)

  • 21. [Hyperlipidemia in the elderly].
    Kawano M
    Nihon Rinsho; 2002 May; 60(5):1017-23. PubMed ID: 12029980
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Economic implications of lipid-lowering trials: current considerations in selecting a statin.
    Farmer JA
    Am J Cardiol; 1998 Sep; 82(6A):26M-31M. PubMed ID: 9766345
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Statins and risk of coronary heart disease.
    Clemenson ND
    JAMA; 2000 Jun; 283(22):2935; author reply 2936. PubMed ID: 10865266
    [No Abstract]   [Full Text] [Related]  

  • 24. Statins and risk of coronary heart disease.
    Ebrahim S; Smith GD
    JAMA; 2000 Jun; 283(22):2935-6. PubMed ID: 10865267
    [No Abstract]   [Full Text] [Related]  

  • 25. The cost-effectiveness of HMG-CoA reductase inhibitors to prevent coronary heart disease. Estimating the benefits of increasing HDL-C.
    Hamilton VH; Racicot FE; Zowall H; Coupal L; Grover SA
    JAMA; 1995 Apr; 273(13):1032-8. PubMed ID: 7897787
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Statin therapy in older persons: pertinent issues.
    Grundy SM
    Arch Intern Med; 2002 Jun; 162(12):1329-31. PubMed ID: 12076230
    [No Abstract]   [Full Text] [Related]  

  • 27. Cost-effectiveness of HMG coenzyme reductase inhibitors; whom to treat?
    van Hout BA; Simoons ML
    Eur Heart J; 2001 May; 22(9):751-61. PubMed ID: 11350107
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lipid-lowering therapy in patients with coronary artery disease: sex or age bias?
    Sgadari A; Incalzi RA; Onder G; Pedone C; Gambassi G
    Arch Intern Med; 2000 Sep; 160(17):2684-5. PubMed ID: 10999995
    [No Abstract]   [Full Text] [Related]  

  • 29. Underutilization of lipid-lowering therapy in coronary artery disease.
    Batalla A; Hevia S; Reguero JR; Cubero GI
    Arch Intern Med; 2000 Sep; 160(17):2683-4. PubMed ID: 10999994
    [No Abstract]   [Full Text] [Related]  

  • 30. The analysis by Manuel and colleagues creates controversy with headlines, not data.
    Genest J; McPherson R; Frohlich J; Fodor G
    CMAJ; 2005 Apr; 172(8):1033-4; discussion 1037. PubMed ID: 15824410
    [No Abstract]   [Full Text] [Related]  

  • 31. Cholesterol management in theory and practice.
    Gotto AM
    Circulation; 1997 Dec; 96(12):4424-30. PubMed ID: 9416913
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pravastatin. A pharmacoeconomic review of its use in primary and secondary prevention of coronary heart disease.
    Coukell AJ; Wilde MI
    Pharmacoeconomics; 1998 Aug; 14(2):217-36. PubMed ID: 10186462
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Gauging the impact of statins using number needed to treat.
    Kumana CR; Cheung BM; Lauder IJ
    JAMA; 1999 Nov; 282(20):1899-901. PubMed ID: 10580441
    [No Abstract]   [Full Text] [Related]  

  • 34. [Guideline for management of lipid metabolism].
    Ishibashi S
    Nihon Rinsho; 2002 Sep; 60 Suppl 9():675-8. PubMed ID: 12387068
    [No Abstract]   [Full Text] [Related]  

  • 35. [ALLHAT [Antihypertensive and Lipid Lowering Treatment to Prevent Heart Attack Trial]].
    Tomiyama H; Doba N
    Nihon Rinsho; 2001 Mar; 59 Suppl 3():393-7. PubMed ID: 11347101
    [No Abstract]   [Full Text] [Related]  

  • 36. Cost-effectiveness of statins.
    Huse DM; Russell MW; Miller JD; Kraemer DF; D'Agostino RB; Ellison RC; Hartz SC
    Am J Cardiol; 1998 Dec; 82(11):1357-63. PubMed ID: 9856919
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cost-effectiveness of 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase inhibitor therapy in the managed care era.
    Jacobson TA
    Am J Cardiol; 1996 Sep; 78(6A):32-41. PubMed ID: 8875973
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Treatment of high blood cholesterol in patients with coronary heart disease].
    Nagai Y; Yamashita S
    Nihon Rinsho; 2003 Apr; 61 Suppl 4():675-81. PubMed ID: 12735049
    [No Abstract]   [Full Text] [Related]  

  • 39. Perspectives in the treatment of dyslipidemias in the prevention of coronary heart disease.
    Borgia MC; Medici F
    Angiology; 1998 May; 49(5):339-48. PubMed ID: 9591525
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Efficacy of lipid reduction therapy in patients with coronary disease].
    Saito S; Takayama T; Hone J; Hirayama A
    Nihon Naika Gakkai Zasshi; 2007 Mar; 96(3):435-40. PubMed ID: 17419407
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.